Recent News

• 05.12.2025 - ArriVent BioPharma Reports First Quarter 2025 Financial Results
• 05.12.2025 - ArriVent BioPharma Reports First Quarter 2025 Financial Results
• 04.28.2025 - ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors
• 04.28.2025 - ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors
• 03.03.2025 - ArriVent BioPharma Reports Full Year 2024 Financial Results
• 03.03.2025 - ArriVent BioPharma Reports Full Year 2024 Financial Results

Recent Filings

• 04.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.29.2025 - 3 Initial statement of beneficial ownership of securities
• 04.28.2025 - EX-99.1 EX-99.1
• 04.28.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.28.2025 - 8-K Current report
• 04.28.2025 - ARS Annual Report to Security Holders
• 04.28.2025 - DEF 14A Other definitive proxy statements
• 03.13.2025 - 8-K Current report
• 03.03.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.03.2025 - 8-K Current report